International Journal of

Neurology and NeurotherapyISSN: 2378-3001

Early Online

 Open Access DOI:10.23937/2378-3001/1410103

What is the Real Impact of SARS-CoV-2 on Stroke: Do We More Have to Learn?

Luiz Severo Bem Junior, Luís Felipe Gonçalves de Lima, Júlio Cesár Tavares Marques, Pedro Lukas do Rêgo Aquino, Andrey Maia Silva Diniz, Artêmio José Araruna Dias, Flávio Monteiro de Oliveira Júnior, Nicollas Nunes Rabelo, Hildo Rocha Cirne de Azevedo Filho

Article Type: Systematic Review | First Published: September 09, 2020

Coronaviruses (CoV) is virus infectious disease witch a considerable spectrum of clinical presentation. Neurologic symptoms related to SARS-CoV-2 have been described recently in the literature. Among a wide variety of neurological symptoms, acute cerebrovascular disease is one of the most serious complications. This review aimed to reveal the current knowledge regarding stroke in new coronavirus infection as way to improve its diagnosis and treatments. A systematic literature review was carried ...

 Open Access DOI:10.23937/2378-3001/1410102

Mononeuritis Multiplex Associated with Sars-Cov2-Covid-19 Infection: Case Report

Enrique Estévez-Rivera, MD, Javier Benavides-Hinestroza, MD, Hernando Rubiano, MD, Herney Andrés García-Perdomo, MD

Article Type: Case Report | First Published: September 09, 2020

We present the case of a 63-year-old female patient from Ipiales (Nariño, Colombia) with COVID-19 Pneumonia (positive PCR test on April 9, 2020, repeated on April 29, 2020, confirming the diagnosis). He was hospitalized in the ICU for 50 days and required prolonged mechanical ventilation. Significant pathological history: Hypertension and hypothyroidism. During her ICU hospitalization, she had kidney failure that required several dialysis sessions. Simultaneously, she showed persistent febrile ...

 Open Access DOI:10.23937/2378-3001/1410101

Migraines and CGRP Monoclonal Antibodies: A Review of Cardiovascular Side Effects and Safety Profile

Kimberly Boldig, MMS and Nitin Butala, MD

Article Type: Review Article | First Published: July 31, 2020

Migraine headaches are a very common complaint described by patients and few medications have been designed solely for their treatment. Current knowledge of migraine pathogenesis relates to various neuropeptides, including calcitonin gene related peptide (CGRP), acting on blood vessels within the brain and causing vasodilation. Sensory fibers detect this change and it is perceived as pain. This understanding has led to the development of CGRP monoclonal antibodies as possible migraine treatment....

Volume 7
Issue 2